References
- Coutts R. T., Foster B. C., Jones G. R., Myers G. E. Metabolism of N‐(n‐propyl)amphetamine by Cunninghamella echinulata. Applied and Environmental Microbiology 1979; 37: 429–432
- Foster B. C., Coutts R. T., Pasutto F. M., Mozayai A. Microbial metabolism of phenelzine and pheniprazine. Life Sciences 1988; 42: 285–292
- Kristensen M. B. Drug interactions and clinical pharmacokinetics. Clinical Pharmacokinetics 1976; 1: 351–372
- Kwong E. C., Shen D. D. Versatile isocratic high‐performance liquid chromatographic assay for propranolol and its basic, neutral and acidic metabolites in biological fluids. Journal of Chromatography 1987; 414: 365–379
- Lennard M. S., Tucker G. T., Silas J. H., Woods H. F. Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenolol. Xenobiotica 1986; 16: 435–447
- Nazarali A. J., Coutts R. T., Pasutto F. M., Foster B. C. Fungal biotransfromations in an airlift bioreactor. Canadian Society of Microbiology, Annual Meeting. 1983, Abstract
- Otton S. V., Inaba T., Kalow W. Competitive inhibition of sparteine oxidation in human liver by β‐adrenoceptor antagonists and other cardiovascular drugs. Life Sciences 1984; 34: 73–80
- Otton S. V., Brinn R. U., Gram L. F. In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver. Drug Metabolism and Disposition 1988; 16: 15–17
- Pearson R. M., Hong C. Y., Patel L. G., Turner P., Potts D. M., Wheeler R., Zipper J. Studies on membrane‐active vaginal spermicides. Contraceptive Delivery Systems 1984; 5: 303–309
- Peterson R. N., Freund M. The inhibition of the motility of human spermatozoa by various pharmacologic agents. Biology of Reproduction 1975; 13: 552–556
- Pritchard J. F., Schneck D. W., Hayes A. H., Jr. Determination of propranolol and six metabolites in human urine by high‐pressure liquid chromatography. Journal of Chromatography 1979; 162: 47–58
- Qureshi S. A., Buttar H. S. High performance liquid chromatographic determination of propranolol and its metabolites in rat serum. Journal of Chromatography 1988; 431: 465–470
- Shand D. G., Rangno R. E., Evans G. H. The disposition of propranolol. II. Hepatic elimination. Pharmacology 1972; 8: 344–352
- Smith R. L. Polymorphism in drug metabolism—implications for drug toxicity. Archives of Toxicology, Supplement 1986; 9: 138–146
- Smith R. V., Rosazza J. P. Microbial models of mammalian metabolism. Journal of Pharmaceutical Sciences 1975; 64: 1737–1759
- Walle T., Gaffney T. E. Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. Journal of Pharmacology and Experimental Therapeutics 1972; 182: 83–92
- Walle T., Morrison J., Walle K., Conradi E. Simultaneous determination of propranolol and 4‐hydroxypropranolol in plasma by mass fragmentography. Journal of Chromatography 1975; 114: 351–359
- Walle T., Fagan T. C., Conradi E. C., Walle U. K., Gaffney T. E. Presystemic and systemic glucuronidation of propranolol. Clinical Pharmacology 1979; 26: 167–172
- Zipper J., Bruzzone M. E., Angelo S., Munoz V., Wheeler R. G. Effect of topically applied adrenergic blockers on fertility. International Journal of Fertility 1982; 27: 342–345
- Zipper J., Wtheeler R. G., Potts D. M., Rivera M. Propranolol as a novel, effective spermicide: preliminary findings. British Medical Journal 1983; 287: 1245–1246